This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Ponvory (ponesimod)
General Description:
Ponvory (ponesimod) is an oral, once-daily prescription medication used for the treatment of active relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Ponvory is a selective sphingosine-1-phosphate (S1P1) receptor modulator that works by reducing the migration of lymphocytes from lymph nodes into the central nervous system. This helps limit inflammation and prevent damage to nerve cells, effectively controlling MS disease activity and reducing relapses.
Disease Indications:
Multiple Sclerosis (MS)
Manufacturer:
Janssen Pharmaceutica
Usage:
Oral
Medicine Approved by:
• European Medicines Agency (EMA)
• Food and Drug Administration (FDA)
Package:
• 14-day starter pack
• 30 tablets × 20 mg
Shipping:
Room Temperature Shipping
Ponvory is stable at room temperature and does not require refrigeration. It is shipped under standard temperature-controlled conditions (15°C to 25°C) to ensure consistent quality and potency during transit.
Standard room temperature shipping is cost-effective and ensures that Ponvory arrives safe, stable, and fully effective for use.
How to Access Ponvory (ponesimod) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Ponvory (ponesimod) is not yet approved or commercially available in India, MitoGENE can assist patients and healthcare providers in legally obtaining it through the Named Patient Program (NPP).
Here’s how the process works:
